Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 15.95 USD -2.92%
Market Cap: 1.5B USD
Have any thoughts about
Arcus Biosciences Inc?
Write Note

Arcus Biosciences Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcus Biosciences Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Arcus Biosciences Inc
NYSE:RCUS
PP&E Net
$48m
CAGR 3-Years
-9%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
PP&E Net
$5.1B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.4B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
14%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6.2B
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$2.5B
CAGR 3-Years
23%
CAGR 5-Years
26%
CAGR 10-Years
13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.4B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
18%

See Also

What is Arcus Biosciences Inc's PP&E Net?
PP&E Net
48m USD

Based on the financial report for Sep 30, 2024, Arcus Biosciences Inc's PP&E Net amounts to 48m USD.

What is Arcus Biosciences Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
37%

Over the last year, the PP&E Net growth was -4%. The average annual PP&E Net growth rates for Arcus Biosciences Inc have been -9% over the past three years , 37% over the past five years .

Back to Top